» Articles » PMID: 18385071

NOD2, the Gene Responsible for Familial Granulomatous Uveitis, in a Mouse Model of Uveitis

Overview
Specialty Ophthalmology
Date 2008 Apr 4
PMID 18385071
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: NOD2 plays an important role in the recognition of intracellular bacteria through its ability to sense the components of bacterial peptidoglycan (PGN), namely muramyl dipeptide (MDP) and muramyl tripeptide (MTP). Specific mutations in the human NOD2 gene cause Blau syndrome, an autosomal dominant form of uveitis, arthritis, and dermatitis. As a first step toward understanding the role of NOD2 in the pathogenesis of uveitis, the authors developed a mouse model of MDP-dependent uveitis.

Methods: BALB/c mice and mice deficient in L-selectin or NOD2 received intravitreal injection of MDP, MTP, or PGN. The intravascular response within the iris and cellular infiltration was quantified by intravital microscopy and histologic assessment.

Results: MDP induced an acute, ocular inflammatory response, wherein rolling and adhering leukocytes within the vasculature were significantly increased within 6 hours after MDP treatment. A minor increase in cellular infiltration occurred at 12 hours after MDP treatment. The adhesion molecule L-selectin participated in MDP-induced vascular inflammation because L-selectin knockout mice showed a significant decrease in the number of rolling cells. Importantly, NOD2 plays an essential role in ocular inflammation induced by MDP, as indicated by the fact that uveitis did not develop in Nod2 knockout mice in response to MDP. Nod2 knockout mice also showed abolished ocular inflammation in response to MTP but not to PGN treatment.

Conclusions: These findings demonstrate a novel mouse model of uveitis, wherein NOD2 plays an essential role in inflammation induced by the minimal components of PGN. Thus, innate immune responses mediated by NOD2 may participate in the development of uveitis in response to bacterial products.

Citing Articles

T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.

Napier R, Lee E, Davey M, Vance E, Furtado J, Snow P Nat Commun. 2020; 11(1):5406.

PMID: 33106495 PMC: 7589501. DOI: 10.1038/s41467-020-18961-0.


Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens.

Juan C, Torrens G, Barcelo I, Oliver A Microbiol Mol Biol Rev. 2018; 82(4).

PMID: 30209071 PMC: 6298613. DOI: 10.1128/MMBR.00033-18.


Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.

Bumgardner S, Zhang L, LaVoy A, Andre B, Frank C, Kajikawa A PLoS One. 2018; 13(5):e0196950.

PMID: 29734365 PMC: 5937747. DOI: 10.1371/journal.pone.0196950.


Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.

Dugan J, Griffiths E, Snow P, Rosenzweig H, Lee E, Brown B J Immunol. 2014; 194(1):349-57.

PMID: 25429073 PMC: 4722953. DOI: 10.4049/jimmunol.1402330.


Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis.

Lee E, Allensworth J, Clowers J, Rosenzweig H Clin Exp Ophthalmol. 2014; 43(4):349-57.

PMID: 25255917 PMC: 4375092. DOI: 10.1111/ceo.12438.


References
1.
Girardin S, Travassos L, Herve M, Blanot D, Boneca I, Philpott D . Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 2003; 278(43):41702-8. DOI: 10.1074/jbc.M307198200. View

2.
Chamaillard M, Philpott D, Girardin S, Zouali H, Lesage S, Chareyre F . Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003; 100(6):3455-60. PMC: 152314. DOI: 10.1073/pnas.0530276100. View

3.
Li T, Fox K, Fox A, Pakalnis V . Recurrent anterior uveitis induced by multiple systemic injections of muramyl dipeptide. Exp Eye Res. 1993; 57(1):79-87. DOI: 10.1006/exer.1993.1101. View

4.
Waters R, Terrell T, Jones G . Uveitis induction in the rabbit by muramyl dipeptides. Infect Immun. 1986; 51(3):816-25. PMC: 260971. DOI: 10.1128/iai.51.3.816-825.1986. View

5.
Herskovits A, Auerbuch V, Portnoy D . Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 2007; 3(3):e51. PMC: 1839167. DOI: 10.1371/journal.ppat.0030051. View